[What is proven in the treatment of complement-mediated kidney diseases?]

Jessica Kaufeld1, Svjetlana Lovric2

  • 1Klinik für Nieren- und Hochdruckerkrankungen, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland. kaufeld.jessica@mh-hannover.de.

PubMed

Insights

Dysregulated complement system activation causes kidney diseases like atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy. Novel therapies targeting the complement system offer new treatment options for these complex conditions.

Area of Science:

  • The complement system, a vital part of innate immunity, involves proteins essential for pathogen defense and homeostasis.
  • Dysregulation of this system can trigger exaggerated responses, leading to kidney damage and diseases.

Context:

  • Complement-mediated kidney diseases, including atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (a form of MPGN), arise from complement system dysregulation.
  • Immune complex deposition in glomeruli can activate complement, driving kidney disease progression.

Purpose:

  • To provide an overview of complement regulation mechanisms.
  • To explain the pathophysiology of complement-mediated kidney diseases.
  • To highlight recent advancements in diagnosis and therapy.

Summary:

  • Diagnosing these kidney diseases involves investigating triggers, genetic factors, and specific complement levels.
  • New therapeutic strategies focus on drugs that specifically target complement system activation, differing from traditional immunosuppressants.
  • An interdisciplinary approach is crucial for understanding and managing these complex conditions.

Impact:

  • Advances in understanding complement regulation and pathophysiology are improving diagnostic accuracy.
  • Targeted therapies offer promising new treatment avenues for patients with complement-mediated kidney diseases.
  • Emphasizes the need for collaborative research and clinical management for better patient outcomes.

Related Concept Videos

Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
1.7K
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.2K
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.2K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
57
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
478
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
269